ACSS2 deficiency inhibits activity of lipid transporters and fatty acid oxidation genes, which then lowers dietary lipid absorption, reduces triglyceride content [29], and lessens hepatic fibrosis [30]. The gene discussed is ACSS2; the disease is Hepatic fibrosis.